In the present study, we found that serum IL-17A levels were elevated in recurrent patients in both discovery and validation cohorts, and serum IL-17A exhibits a potential predictive value for CRSwNP recurrence. This evidence concerns the gene IL17A and chronic rhinosinusitis with nasal polyps.